No products in the cart.
Human coronaviruses cause infections of the nose, throat and lungs, they are most spread from an infected person.
Human coronaviruses cause infections of the nose, throat and lungs, they are most spread from an infected person.
In 2017, The Egyptian-American Enterprise Fund (“EAEF”) acquired a significant minority stake in Orchidia Pharmaceutical Industries. The transaction is being executed through EAEF’s investment manager Lorax Capital Partners (“LCP”). The Current shareholding structure consists of EAEF and Dr. Ossama Abbass, the founder, majority shareholder and Chairman of the Company.
About the Egyptian-American Enterprise Fund:
The Egyptian-American Enterprise Fund is a United States government-funded private entity. Since the inception of the Enterprise Fund Program, over US$ 1.1 billion has been invested directly alongside US$6.9 billion invested by private parallel funds.
With an anticipated capital of up to US$300 million, EAEF is committed to promoting financial inclusion, job creation and increasing foreign and domestic investment in Egypt for long-term sustainable economic development. EAEF’s primary mission is to stimulate the Egyptian private sector by providing access to finance, human capital, modern technologies as well as best business practices while achieving financial profitability.
The fund is led by a board of directors that is primarily comprised of American, Egyptian-American and Egyptian nationals.
Further details on the Egyptian-American Enterprise Fund can be found at http://www.eaefund.org
The U.S. Agency for International Development administers the U.S. foreign assistance program providing economic and humanitarian assistance in more than 80 countries worldwide.
This press release about an EAEF investment is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the Egyptian-American Enterprise Fund and do not necessarily reflect the views of USAID or the United States Government.
About Lorax Capital Partners:
Incorporated in 2015, Lorax Capital Partners (“LCP”) is an Egypt focused private equity firm currently managing the EAEF funds and was responsible for EAEF’s investments in Fawry for Banking and Payment Technology Services, the leading electronic payments platform in Egypt and Sarwa Capital, a pioneer in consumer finance, leasing, and securitization in Egypt. LCP is very well positioned to serve as a ‘bridge’ between Egypt, on the one hand, and global investors that are looking to generate attractive risk-adjusted returns while contributing to the economic development of the country.
LCP’s management team has an unmatched track record in sourcing, executing and managing transactions in Egypt with a combined value of over USD 46 billion.